Indivior Pharmaceuticals, Inc. (E7P)

Profile

https://www.indivior.com

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on medications for opioid use disorder and related addiction treatment needs. Its portfolio includes prescription therapies such as Sublocade, Suboxone, and Subutex, which are used in clinical settings to support recovery and ongoing management of dependence. The company also develops treatments for overdose reversal and other substance use disorders, reflecting its emphasis on evidence-based addiction medicine. Indivior Pharmaceuticals, Inc. serves healthcare providers, treatment programs, and patients across markets where access to medically supervised addiction care is an important part of public health. By concentrating on this therapeutic area, the company plays a specialized role in the pharmaceutical market, addressing a segment that combines chronic disease management, patient support, and regulated medical treatment.